EUVIMEDEUVIMED entdecken
Crossref

Initial Surgical Management of Medullary Thyroid Cancer

Kathryn E Coan, Tracy S Wang

International Journal of Endocrine Oncology · 2016

DOI: 10.2217/ije-2015-0009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Endocrine Oncology, 2016. Verfasst von Kathryn E Coan und 1 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Medullary thyroid cancer (MTC) accounts for 5–10% of thyroid cancer. The majority, 75–80%, of MTC are sporadic with the remainder being hereditary secondary to a mutation in the RET proto-oncogene. Hereditary MTC may be isolated as in familial medullary thyroid cancer or associated with multiple endocrine neoplasia syndrome types 2A and 2B. The primary treatment modality for sporadic MTC is total thyroidectomy and central compartment neck dissection; consideration of lateral neck dissection should be based on preoperative imaging findings. The timing of prophylactic thyroidectomy is dependent on the specific RET codon mutation.

Zitieren

APA

Coan, K. E., & Wang, T. S. (2016). Initial Surgical Management of Medullary Thyroid Cancer. International Journal of Endocrine Oncology. https://doi.org/10.2217/ije-2015-0009

Vancouver

Coan KE, Wang TS. Initial Surgical Management of Medullary Thyroid Cancer. International Journal of Endocrine Oncology. 2016. doi:10.2217/ije-2015-0009

BibTeX
@article{Coan2016,
  author = {Coan, Kathryn E and Wang, Tracy S},
  title = {Initial Surgical Management of Medullary Thyroid Cancer},
  journal = {International Journal of Endocrine Oncology},
  year = {2016},
  doi = {10.2217/ije-2015-0009}
}
Kostenlos starten →